Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19238311rdf:typepubmed:Citationlld:pubmed
pubmed-article:19238311lifeskim:mentionsumls-concept:C1801960lld:lifeskim
pubmed-article:19238311lifeskim:mentionsumls-concept:C0011884lld:lifeskim
pubmed-article:19238311lifeskim:mentionsumls-concept:C0540511lld:lifeskim
pubmed-article:19238311lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:19238311lifeskim:mentionsumls-concept:C0020456lld:lifeskim
pubmed-article:19238311lifeskim:mentionsumls-concept:C0035331lld:lifeskim
pubmed-article:19238311lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:19238311lifeskim:mentionsumls-concept:C1176299lld:lifeskim
pubmed-article:19238311pubmed:issue1lld:pubmed
pubmed-article:19238311pubmed:dateCreated2010-2-4lld:pubmed
pubmed-article:19238311pubmed:abstractTextOur previous data suggested that angiopoietin-2 (Ang-2) is linked to pericyte loss, thereby playing an important role in diabetic retinopathy. In this study, we investigated the effect of retinal overexpression of human Ang-2 (mOpsinhAng2 mouse) on vascular morphology in non-diabetic and streptozotozin-induced diabetic animals. Pericyte (PC) coverage and acellular capillary (AC) formation were quantitated in retinal digest preparations after 3 and 6 months of diabetes duration. The degree of retinopathy in non-diabetic mOpsinhAng2 mice at 3 months (-21% PC, +49% AC) was comparable to age-matched diabetic wild type mice. Diabetic mOpsinhAng2 mice exhibited significantly worse vascular pathology than wild type counterparts at 6 months. Quantitative PCR revealed that human Ang-2 mRNA was highly overexpressed in retinas of transgenic mice. Our data demonstrate that overexpression of Ang-2 in the retina enhances vascular pathology, indicating that Ang-2 plays an essential role in diabetic vasoregression via destabilization of pericytes.lld:pubmed
pubmed-article:19238311pubmed:languageenglld:pubmed
pubmed-article:19238311pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19238311pubmed:citationSubsetIMlld:pubmed
pubmed-article:19238311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19238311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19238311pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19238311pubmed:statusMEDLINElld:pubmed
pubmed-article:19238311pubmed:monthMarlld:pubmed
pubmed-article:19238311pubmed:issn1432-5233lld:pubmed
pubmed-article:19238311pubmed:authorpubmed-author:WangYumeiYlld:pubmed
pubmed-article:19238311pubmed:authorpubmed-author:SchreiterKayKlld:pubmed
pubmed-article:19238311pubmed:authorpubmed-author:HammesHans-Pe...lld:pubmed
pubmed-article:19238311pubmed:authorpubmed-author:FengYuxiYlld:pubmed
pubmed-article:19238311pubmed:authorpubmed-author:HoffmannSigri...lld:pubmed
pubmed-article:19238311pubmed:authorpubmed-author:DeutschUrbanUlld:pubmed
pubmed-article:19238311pubmed:authorpubmed-author:vom...lld:pubmed
pubmed-article:19238311pubmed:authorpubmed-author:PfisterFreder...lld:pubmed
pubmed-article:19238311pubmed:authorpubmed-author:AltvaterKarin...lld:pubmed
pubmed-article:19238311pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19238311pubmed:volume47lld:pubmed
pubmed-article:19238311pubmed:ownerNLMlld:pubmed
pubmed-article:19238311pubmed:authorsCompleteYlld:pubmed
pubmed-article:19238311pubmed:pagination59-64lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:meshHeadingpubmed-meshheading:19238311...lld:pubmed
pubmed-article:19238311pubmed:year2010lld:pubmed
pubmed-article:19238311pubmed:articleTitleRetinal overexpression of angiopoietin-2 mimics diabetic retinopathy and enhances vascular damages in hyperglycemia.lld:pubmed
pubmed-article:19238311pubmed:affiliation5th Medical Clinic, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.lld:pubmed
pubmed-article:19238311pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19238311pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed